Alba Ginés

Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer

Eva Martinez‐Balibrea, Albert Abad, Enrique Aranda et al. · European Journal of Cancer · 2008 · 72 citations

Medicine, Oncology, Pharmacology +17

Increased levels of copper efflux transporter ATP7B are associated with poor outcome in colorectal cancer patients receiving oxaliplatin‐based chemotherapy

Eva Martinez‐Balibrea, Anna Martínez‐Cardús, Eva Musulén et al. · International Journal of Cancer · 2009 · 70 citations · Full text

Medicine, Oncology, Pharmacology +17

A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines

Eva Martinez‐Balibrea, Carmen Plasencia, Alba Ginés et al. · Molecular Cancer Therapeutics · 2009 · 66 citations

Medicine, Oncology, Pharmacology +17

Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer

Anna Martínez‐Cardús, Eva Martinez‐Balibrea, Eva Bandrés et al. · Molecular Cancer Therapeutics · 2009 · 65 citations

Medicine, Oncology, Pharmacology +17

PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines

Alba Ginés, Sara Bystrup, Vicenç Ruiz de Porras et al. · PLoS ONE · 2015 · 38 citations · Full text

Medicine, Molecular Biology, Oncology +15